drugset / Trial / NCT01540825
First in Man Trial of BI 113608
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the current study is to investigate the safety and tolerability of BI 113608 in healthy male volunteers following oral administration of single rising doses. A secondary objective is the exploration of the pharmacokinetics of BI 113608 after single dosing.
Timeline
- Start
- 2012-02
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 113608 | Unknown | — | Oral |
Indications
No indication recorded.